o-demethyltramadol has been researched along with Cancer Pain in 3 studies
*Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Itoh, K; Kawakami, J; Naito, T; Suzuki, K; Tanaka, H; Yamada, Y | 1 |
| Itoh, K; Kawakami, J; Naito, T; Shibata, K; Suzuki, K; Tanaka, H; Yamada, Y | 1 |
| Hiraide, T; Kawakami, J; Naito, T; Sato, H; Tanaka, H; Yamada, Y | 1 |
3 other study(ies) available for o-demethyltramadol and Cancer Pain
| Article | Year |
|---|---|
A Reversed-Phase Mode LC-MS/MS Method Using a Polysaccharide Chiral Selector for Simultaneous Quantitation of Each Enantiomer of Tramadol and its Metabolites in Human Plasma and Evaluation of CYP-Mediated Stereoselective Demethylation.
Topics: Analgesics, Opioid; Cancer Pain; Chromatography, Liquid; Cytochrome P-450 Enzyme System; Humans; Polysaccharides; Reproducibility of Results; Stereoisomerism; Tandem Mass Spectrometry; Tramadol | 2020 |
Impact of CYP2D6 activity and cachexia progression on enantiomeric alteration of plasma tramadol and its demethylated metabolites and their relationships with central nervous system symptoms in head and neck cancer patients.
Topics: Aged; Cachexia; Cancer Pain; Cytochrome P-450 CYP2D6; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Stereoisomerism; Tramadol | 2021 |
Impact of CYP genotype and inflammatory markers on the plasma concentrations of tramadol and its demethylated metabolites and drug tolerability in cancer patients.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Asian People; C-Reactive Protein; Cancer Pain; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Interleukin-6; Male; Middle Aged; Neoplasms; Time Factors; Tramadol | 2018 |